WebJul 6, 2024 · Unum Therapeutics Inc. ("Unum") (NASDAQ: UMRX), a biopharmaceutical company focused on developing therapies for solid tumors, today announced it has completed the acquisition of Kiq LLC ("Kiq"), a ... WebUnum Therapeutics Inc. (UMRX) Company Bio. Unum Therapeutics Inc., a clinical stage biopharmaceutical company, develops and commercializes immunotherapy products designed to harness the power of a patient’s immune system to cure cancer. Its lead product candidate is the ACTR087 used in combination with rituximab, which is in Phase I clinical ...
Unum Therapeutics Announces Company Name Change to Cogent
WebJun 8, 2015 · Unum Therapeutics uses proprietary T-cell engineering technology in combination with tumor-targeting antibodies to activate the body’s own immune system … street washington dc
Unum Therapeutics Announces Company Name Change to …
WebAug 31, 2024 · PRAGUE, Czech Republic and CAMBRIDGE, USA, August 31, 2024 / B3C newswire / --SOTIO, a clinical stage immuno-oncology company owned by PPF Group, today announced that it has acquired the rights to Unum Therapeutics’ (Nasdaq: UMRX) BOXR cell therapy platform and BOXR lead programs to develop novel T cell therapies for the … WebDental providers — Join our dental network. Unum is a trusted leader in employee benefits with a growing dental provider network. Participating providers can grow their practice with a trusted partner and enjoy simplified electronic claims submission, fast payment options and an in-house team dedicated to helping our network providers focus on what matters the … WebCogent Biosciences 8,652 followers on LinkedIn. Precision therapeutics for genetically defined diseases. Real solutions for real challenges. Cogent Biosciences is a … street watch west midlands forum